That test maps 14 pathways and 150+ genetic insights to optimize your peptide therapyfar more targeted than adding an unproven antioxidant supplement
The results of PET imaging clearly confirmed the accumulation of 18 F-FGln in the GBM (rat model) [149]
According to Egan, it took the brand one year to develop and when it launched, it far exceeded the team's expectations, ultimately leading to a significant pivot for the company
Data are represented as mean standard error of the mean (SEM)
Understanding these predispositions does not guarantee outcomes, but may support a more nuanced discussion about whether dual-peptide approaches, microdose protocols, or standard formulations align with your genetic landscape
The company emphasizes technology-enabled tracking systems that monitor adherence, biometric data and engagement over time, giving employers aggregated reporting on outcomes while maintaining patient privacy